Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report
Abstract
:1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Adalja, A.; Inglesby, T. A Novel International Monkeypox Outbreak. Ann. Intern. Med. 2022, 175, 1175–1176. [Google Scholar] [CrossRef]
- Genital Monkeypox Superimposed on Co-Incident Sexually Transmitted Infections in AIDS Patient; A Case Report-PMC. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523066/?report=classic (accessed on 27 October 2022).
- CDC. Monkeypox in the U.S. Centers for Disease Control and Prevention. 2022. Available online: https://www.cdc.gov/poxvirus/monkeypox/index.html (accessed on 27 October 2022).
- Philpott, D.; Hughes, C.M.; Alroy, K.A.; Kerins, J.L.; Pavlick, J.; Asbel, L.; Crawley, A.; Newman, A.P.; Spencer, H.; Feldpausch, A.; et al. Epidemiologic and Clinical Characteristics of Monkeypox Cases-United States, May 17–July 22, 2022. MMWR Morb. Mortal. Wkly. Rep. 2022, 71, 1018–1022. [Google Scholar] [CrossRef]
- Spicknall, I.H.; Pollock, E.D.; Clay, P.A.; Oster, A.M.; Charniga, K.; Masters, N.; Nakazawa, Y.J.; Rainisch, G.; Gundlapalli, A.V.; Gift, T.L. Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex with Men—United States, 2022. Morb. Mortal. Wkly. Rep. 2022, 71, 1131–1135. [Google Scholar] [CrossRef]
- Alakunle, E.; Moens, U.; Nchinda, G.; Okeke, M.I. Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses 2020, 12, 1257. [Google Scholar] [CrossRef] [PubMed]
- Petersen, B.; Agam, R.; Yom, Y. Guidance for Tecovirimat Use (2023) Centers for Disease Control and Prevention. Available online: https://www.cdc.gov/poxvirus/mpox/clinicians/Tecovirimat.html#references (accessed on 10 November 2022).
- Manoharan, A.; Braz, B.X.; McBride, A.; Hernandez, S.; Balfour, M.; Quiroz, T.; Powell, A.; Rodriguez, A.; Morris, S.; Gonzales-Zamora, J.A. Severe monkeypox with superimposed bacterial infection in an immunocompetent patient: A case report. IDCases 2022, 30, e01626. [Google Scholar] [CrossRef] [PubMed]
- Hoffmann, C.; Jessen, H.; Wyen, C.; Grunwald, S.; Noe, S.; Teichmann, J.; Krauss, A.; Kolarikal, H.; Scholten, S.; Schuler, C.; et al. Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany. HIV Med. 2022. [Google Scholar] [CrossRef]
- Nolasco, S.; Vitale, F.; Geremia, A.; Tramuto, F.; Maida, C.M.; Sciuto, A.; Coco, C.; Manuele, R.; Frasca, E.; Frasca, M.; et al. First case of monkeypox virus, SARS-CoV-2 and HIV co-infection. J. Infect. 2023, 86, e21–e23. [Google Scholar] [CrossRef]
- Ratnam, I.; Chiu, C.; Kandala, N.B.; Easterbrook, P.J. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin. Infect. Dis. 2006, 42, 418–427. [Google Scholar] [CrossRef]
- DeSimone, J.A.; Pomerantz, R.J.; Babinchak, T.J. Inflammatory Reactions in HIV-1–Infected Persons after Initiation of Highly Active Antiretroviral Therapy. Ann. Intern. Med. 2000, 133, 447–454. [Google Scholar] [CrossRef] [PubMed]
- Sereti, I.; Sheikh, V.; Shaffer, D.; Phanuphak, N.; Gabriel, E.; Wang, J.; Nason, M.C.; Roby, G.; Ngeno, H.; Kirui, F.; et al. Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living with Human Immunodeficiency Virus and Severe Lymphopenia. Clin. Infect. Dis. 2020, 71, 652–660. [Google Scholar] [CrossRef] [Green Version]
- Curran, K.G.; Eberly, K.; Russell, O.O.; Snyder, R.E.; Phillips, E.K.; Tang, E.C.; Peters, P.J.; Sanchez, M.A.; Hsu, L.; Cohen, S.E.; et al. HIV and Sexually Transmitted Infections Among Persons with Monkeypox—Eight U.S. Jurisdictions, May 17–July 22, 2022. MMWR Morb. Mortal. Wkly. Rep. 2022, 71, 1141–1147. [Google Scholar] [CrossRef]
- Thornhill, J.P.; Barkati, S.; Walmsley, S.; Rockstroh, J.; Antinori, A.; Harrison, L.B.; Palich, R.; Nori, A.; Reeves, I.; Habibi, M.S.; et al. Monkeypox Virus Infection in Humans across 16 Countries—April–June 2022. N. Engl. J. Med. 2022, 387, 679–691. [Google Scholar] [CrossRef]
- Shafaati, M.; Zandi, M.; Choudhary, O.P. Monkeypox virus crosstalk with HIV; where do we stand now? Int. J. Surg. 2022, 105, 106897. [Google Scholar] [CrossRef]
- Mungmunpuntipantip, R.; Wiwanitkit, V. Monkeypox in HIV Infected Cases: A Summary on Clinical Presentation of 27 Cases. Infect. Chemother. 2022, 54, 549–550. [Google Scholar] [CrossRef] [PubMed]
- Gessain, A.; Nakoune, E.; Yazdanpanah, Y. Monkeypox. N. Engl. J. Med. 2022, 387, 1783–1793. [Google Scholar] [CrossRef]
- Wong, L.; Gonzales-Zamora, J.A.; Beauchamps, L.; Henry, Z.; Lichtenberger, P. Clinical presentation of Monkeypox among people living with HIV in South Florida: A case series. Infez Med. 2022, 4, 610–618. [Google Scholar] [CrossRef]
- Yinka-Ogunleye, A.; Aruna, O.; Dalhat, M.; Ogoina, D.; McCollum, A.; Disu, Y.; Mamadu, I.; Akinpelu, A.; Ahmad, A.; Burga, J.; et al. Outbreak of human monkeypox in Nigeria in 2017-18: A clinical and epidemiological report. Lancet Infect. Dis. 2019, 8, 872–879. [Google Scholar] [CrossRef]
- Ogoina, D.; Iroezindu, M.; James, H.I.; Oladokun, R.; Yinka-Ogunleye, A.; Wakama, P.; Otike-Odibi, B.; Usman, L.M.; Obazee, E.; Aruna, O.; et al. Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin. Infect. Dis. 2020, 71, e210–e214. [Google Scholar] [CrossRef] [PubMed]
- French, M.A.; Price, P.; Stone, S.F. Immune restoration disease after antiretroviral therapy. AIDS 2004, 18, 1615–1627. [Google Scholar] [CrossRef]
- Mfinanga, S.G.; Kirenga, B.J.; Chanda, D.M.; Mutayoba, B.; Mthiyane, T.; Yimer, G.; Ezechi, O.; Connolly, C.; Kapotwe, V.; Muwonge, C.; et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): A prospective, international, randomised, placebo-controlled trial. Lancet Infect. Dis. 2014, 14, 563–571. [Google Scholar] [CrossRef] [PubMed]
- Antonelli, L.R.V.; Mahnke, Y.; Hodge, J.N.; Porter, B.O.; Barber, D.L.; DerSimonian, R.; Greenwald, J.H.; Roby, G.; Mican, J.; Sher, A.; et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 2010, 116, 3818–3827. [Google Scholar] [CrossRef] [Green Version]
- Mori, S.; Polatino, S.; Estrada-Y-Martin, R.M. Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy. Int. J. STD AIDS 2009, 20, 662–665. [Google Scholar] [CrossRef]
- Lederer, P.; Briggs, M.; Hassani, A.S.; Date, A. TB-HAART trial. Lancet Infect. Dis. 2015, 15, 14. [Google Scholar] [CrossRef] [PubMed]
- Jacobson, K.; Ogbuagu, O. Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus–infected patients compared to non-nucleoside and protease inhibitor–based regimens in a real-world clinical setting. Medicine 2018, 97, e13016. [Google Scholar] [CrossRef] [PubMed]
- Zhao, Y.; Hohlfeld, A.; Namale, P.; Meintjes, G.; Maartens, G.; Engel, M.E. Risk of immune reconstitution inflammatory syndrome with integrase inhibitors versus other classes of antiretrovirals: A systematic review and meta-analysis of randomised trials. J. Acquir. Immune Defic. Syndr. 2022, 90, 232–239. [Google Scholar] [CrossRef] [PubMed]
- Simon-Gozalbo, A.; Gamo-Guerrero, M.; Alonso-Garcia, S.; Mauleon-Fernandez, C.; Cuevas-Tascon, G. Haemorrhagic monkeypox infection in an immunosuppressed patient with human immunodeficiency virus: Beyond the pustules. Clin. Microbiol. Infect. 2023, 29, 122–124. [Google Scholar] [CrossRef]
- Raccagni, A.R.; Mileto, D.; Canetti, D.; Tamburini, A.M.; Rizzo, A.; Bruzzesi, E.; Castagna, A.; Nozza, S. Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men. J. Infect. 2022, 85, 436–480. [Google Scholar] [CrossRef]
- Hascoet, J.L.; Dahoun, M.; Cohen, M.; Pommaret, E.; Pilmis, B.; Lemarchand, N.; Mizrahi, A.; Aubert, M.; de Parades, V.; Le Monnier, A. Clinical diagnostic and therapeutic aspects of 221 consecutive anorectal Chlamydia trachomatis and Neisseria gonorrhoeae sexually transmitted infections among men who have sex with men. Int. J. Infect. Dis. 2018, 71, 9–13. [Google Scholar] [CrossRef] [Green Version]
- Pipitò, L.; Trizzino, M.; Ferraro, D.; Cascio, A. Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France. Travel Med. Infect. Dis. 2022, 50, 102469. [Google Scholar] [CrossRef]
- Gedela, K.; Da Silva Fontoura, D.; Salam, A.; Gorman, G.; Golden, J.; O’Hara, G.; Elowaidy, A.; Tittle, V.; Girometti, N.; Whitlock, G.; et al. Infectious Proctitis due to Human Monkeypox. Clin. Infect. Dis. 2023, 76, e1424–e1427. [Google Scholar] [CrossRef]
- O’Shea, J.; Filardo, T.D.; Morris, S.B.; Weiser, J.; Petersen, B.; Brooks, J.T. Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection—United States, August 2022. MMWR Morb. Mortal. Wkly. Rep. 2022, 71, 1023–1028. [Google Scholar] [CrossRef] [PubMed]
- Grosenbach, D.W.; Honeychurch, K.; Rose, E.A.; Chinsangaram, J.; Frimm, A.; Maiti, B.; Lovejoy, C.; Meara, I.; Long, P.; Hruby, D.E. Oral Tecovirimat for the Treatment of Smallpox. N. Engl. J. Med. 2018, 379, 44–53. [Google Scholar] [CrossRef]
- Miller, M.J.; Cash-Goldwasser, S.; Marx, G.E.; Schrodt, C.A.; Kimball, A.; Padgett, K.; Noe, R.S.; McCormick, D.W.; Wong, J.M.; Labuda, S.M.; et al. Severe Monkeypox in Hospitalized Patients-United States, 10 August–10 October 2022. MMWR Morb. Mortal. Wkly. Rep. 2022, 71, 1412–1417. [Google Scholar] [CrossRef] [PubMed]
- DeLaurentis, C.E.; Kiser, J.; Zucker, J. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus. Antimicrob. Agents Chemother. 2022, 66, e0122622. [Google Scholar] [CrossRef] [PubMed]
- CDC Health Update-DHHS. Update on Managing Monkeypox in Patients Receiving Therapeutics. 17 November 2022. Available online: https://dhhs.ne.gov/han%20Documents/UPDATE11182022.pdf (accessed on 24 October 2022).
- Huggins, J.W.; Martinez, M.; Hartmann, C.J.; Hensley, L.E. 17th International Conference on Antiviral Research In: Successful cidofovir treatment of smallpox-like disease in variola and monkeypox primate models. Antivir. Res. 2004, 62, A27–A90. [Google Scholar]
- Stittelaar, K.J.; Neyts, J.; Naesens, L.; van Amerongen, G.; van Lavieren, R.F.; Holy, A.; De Clercq, E.; Niesters, H.G.; Fries, E.; Maas, C.; et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 2006, 439, 745–748. [Google Scholar] [CrossRef]
- Raccagni, A.R.; Candela, C.; Bruzzesi, E.; Mileto, D.; Canetti, D.; Rizzo, A.; Castagna, A.; Nozza, S. Real-life use of cidofovir for the treatment of severe monkeypox cases. J. Med. Virol. 2023, 1, e28218. [Google Scholar] [CrossRef]
- Stafford, A.; Rimmer, S.; Gilchrist, M.; Sun, K.; Davies, E.P.; Waddington, C.S.; Chiu, C.; Armstrong-James, D.; Swaine, T.; Davies, F.; et al. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Lancet Infect. Dis. 2023. [Google Scholar] [CrossRef]
- Fabrizio, C.; Bruno, G.; Cristiano, L.; Buccoliero, G.B. Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome. Infection, 2022; Epub ahead of print. [Google Scholar] [CrossRef]
- Mondi, A.; Gagliardini, R.; Mazzotta, V.; Vita, S.; Carletti, F.; Pinnetti, C.; Giancola, M.L.; Specchiarello, E.; Lanini, S.; Faraglia, F.; et al. Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital. J. Infect. 2023, 86, 66–117. [Google Scholar] [CrossRef]
- Thet, A.K.; Kelly, P.J.; Kasule, S.N.; Shah, A.K.; Chawala, A.; Latif, A.; Chilimuri, S.S.; Zeana, C.B. The Use of Vaccinia Immune Globulin in the Treatment of Severe Monkeypox Virus Infection in HIV/AIDS. Clin. Infect. Dis. 2022, ciac971. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Martinez, A.E.; Frattaroli, P.; Vu, C.A.; Paniagua, L.; Mintz, J.; Bravo-Gonzalez, A.; Zamudio, P.; Barco, A.; Rampersad, A.; Lichtenberger, P.; et al. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report. Vaccines 2023, 11, 650. https://doi.org/10.3390/vaccines11030650
Martinez AE, Frattaroli P, Vu CA, Paniagua L, Mintz J, Bravo-Gonzalez A, Zamudio P, Barco A, Rampersad A, Lichtenberger P, et al. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report. Vaccines. 2023; 11(3):650. https://doi.org/10.3390/vaccines11030650
Chicago/Turabian StyleMartinez, Andres E., Paola Frattaroli, Christine A. Vu, Lizy Paniagua, Joel Mintz, Andres Bravo-Gonzalez, Paola Zamudio, Astrid Barco, Aruna Rampersad, Paola Lichtenberger, and et al. 2023. "Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report" Vaccines 11, no. 3: 650. https://doi.org/10.3390/vaccines11030650
APA StyleMartinez, A. E., Frattaroli, P., Vu, C. A., Paniagua, L., Mintz, J., Bravo-Gonzalez, A., Zamudio, P., Barco, A., Rampersad, A., Lichtenberger, P., & Gonzales-Zamora, J. A. (2023). Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report. Vaccines, 11(3), 650. https://doi.org/10.3390/vaccines11030650